Thermo Fisher has outperformed the market with a 420%+ return over the past decade, but its current valuation is high. Check ...

One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years ...

Thermo Fisher (TMO) stock slips as plant producing RSV treatment. Beyfortus developed by AstraZeneca (AZN), Sanofi (SNY) ...

One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years ...

Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest innovations enabling the molecule-to-medicine journey and host a series of sessions that feature industry ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $598.61 which represents a decrease of $-2.31 or -0.38% from the prior close of $600.92. The stock opened at $602.63 and ...

Fintel reports that on October 1, 2024, Stephens & Co. initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a ...

Implementation of SAF for air shipments of clinical trial materials to meet Thermo Fisher's net-zero commitments.

(Reuters) - One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years has repeatedly breached rules meant to ensure drugs are free ...

Thermo Fisher's Greenville facility, one of the largest in the U.S., has faced repeated FDA regulatory violations. Key concerns include contamination prevention and inadequate equipment sterilization ...

Shares of Thermo Fisher Scientific Inc. TMO slipped 0.38% to $598.61 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5 ...